BIOLASE, Inc.
BIOL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,431 | $4,505 | $57,621 | $25,677 |
| - Cash | $6,566 | $4,181 | $29,972 | $17,564 |
| + Debt | $17,910 | $15,050 | $15,052 | $17,960 |
| Enterprise Value | $12,775 | $15,374 | $42,701 | $26,073 |
| Revenue | $49,164 | $48,462 | $39,188 | $22,780 |
| % Growth | 1.4% | 23.7% | 72% | – |
| Gross Profit | $16,724 | $15,911 | $16,529 | $6,173 |
| % Margin | 34% | 32.8% | 42.2% | 27.1% |
| EBITDA | -$15,442 | -$25,279 | -$13,469 | -$13,843 |
| % Margin | -31.4% | -52.2% | -34.4% | -60.8% |
| Net Income | -$20,632 | -$28,634 | -$16,158 | -$16,829 |
| % Margin | -42% | -59.1% | -41.2% | -73.9% |
| EPS Diluted | -16.14 | -413.19 | -273.41 | -688.19 |
| % Growth | 96.1% | -51.1% | 60.3% | – |
| Operating Cash Flow | -$14,091 | -$26,761 | -$16,710 | -$12,795 |
| Capital Expenditures | -$1,311 | -$3,727 | -$707 | -$96 |
| Free Cash Flow | -$15,402 | -$30,488 | -$17,417 | -$12,891 |